E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/18/2016 in the Prospect News Emerging Markets Daily and Prospect News Investment Grade Daily.

New Issue: Israel’s Teva Pharmaceutical details pricing of $15 billion of notes in six tranches

By Lisa Kerner

Charlotte, N.C., July 19 – Teva Pharmaceutical Industries Ltd. priced $15 billion in six series of fixed-rate senior notes (Baa2/BBB) on Monday, according to details of the issuance in an FWP filed with the Securities and Exchange Commission.

The notes were issued though Teva Pharmaceutical Finance Netherlands III BV and guaranteed by Teva Pharmaceutical Industries.

The company priced $1.5 billion of 1.4% two-year notes at 99.914 to yield 1.444%. The notes sold at Treasuries plus 75 basis points.

A $2 billion tranche of 1.7% three-year notes priced at 99.991 to yield 1.703%, or 85 bps over Treasuries.

Teva priced $3 billion of 2.2% five-year notes at 99.835 to yield 2.235%. The company sold the notes at Treasuries plus 110 bps.

Also, the company brought $3 billion of 2.8% seven-year notes at 145 bps over Treasuries. The notes priced at 99.666 to yield 2.853%.

A $3.5 billion offering of 3.15% notes due Oct. 1, 2026 priced 99.734 to yield 3.18%, or 160 bps over Treasuries.

Teva’s final tranche of $2 billion of 4.1% notes due Oct. 1, 2046 priced at 99.167 to yield 4.148%. The notes sold at 185 bps over Treasuries.

All of the tranches priced at the tight end of price talk, according to a market source.

The company dropped a series of floating-rate notes.

BofA Merrill Lynch, Barclays, BNP Paribas Securities Corp., Credit Suisse Securities (USA) LLC, HSBC Securities (USA) Inc., Mizuho Securities USA Inc., Citigroup Global Markets Inc., Morgan Stanley & Co. LLC, RBC Capital Markets Corp. and SMBC Nikko were the bookrunners.

Teva also planned to price euro- and Swiss franc-denominated notes to help fund its acquisition of the generics business of Allergan plc.

The global pharmaceutical company is based in Jerusalem.

Issuer:Teva Pharmaceutical Finance Netherlands III BV
Guarantor:Teva Pharmaceutical Industries Ltd.
Amount:$15 billion
Description:Senior notes
Bookrunners:BofA Merrill Lynch, Barclays, BNP Paribas Securities Corp., Credit Suisse Securities (USA) LLC, HSBC Securities (USA) Inc., Mizuho Securities USA Inc., Citigroup Global Markets Inc., Morgan Stanley & Co. LLC, RBC Capital Markets Corp., SMBC Nikko
Co-managers:Bank of China Ltd. London Branch, BBVA Securities Inc., Commerz Markets LLC, Lloyds Securities Inc., MUFG, PNC Capital Markets LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC
Trade date:July 18
Settlement date:July 21
Ratings:Moody’s: Baa2
S&P: BBB
Distribution:SEC registered
Two-year notes
Amount:$1.5 billion
Maturity:July 20, 2018
Coupon:1.4%
Price:99.914
Yield:1.444%
Spread:Treasuries plus 75 bps
Price guidance:Treasuries plus 80 bps area, plus or minus 5 bps
Make-whole call: Treasuries plus 12.5 bps
Three-year notes
Amount:$2 billion
Maturity:July 19, 2019
Coupon:1.7%
Price:99.991
Yield:1.703%
Spread:Treasuries plus 85 bps
Price guidance:Treasuries plus 90 bps area, plus or minus 5 bps
Make-whole call: Treasuries plus 15 bps
Five-year notes
Amount:$3 billion
Maturity:July 21, 2021
Coupon:2.2%
Price:99.835
Yield:2.235%
Spread:Treasuries plus 110 bps
Price guidance:Treasuries plus 115 bps area, plus or minus 5 bps
Make-whole call: Treasuries plus 20 bps
Seven-year notes
Amount:$3 billion
Maturity:July 21, 2023
Coupon:2.8%
Price:99.666
Yield:2.853%
Spread:Treasuries plus 145 bps
Price guidance:Treasuries plus 150 bps area, plus or minus 5 bps
Make-whole call: Treasuries plus 25 bps
10-year notes
Amount:$3.5 billion
Maturity:Oct. 1, 2026
Coupon:3.15%
Price:99.734
Yield:3.18%
Spread:Treasuries plus 160 bps
Price guidance:Treasuries plus 165 bps area, plus or minus 5 bps
Make-whole call: Treasuries plus 25 bps
30-year notes
Amount:$2 billion
Maturity:Oct. 1, 2046
Coupon:4.1%
Price:99.167
Yield:4.148%
Spread:Treasuries plus 190 bps
Price guidance:Treasuries plus 185 bps area, plus or minus 5 bps
Make-whole call: Treasuries plus 30 bps

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.